• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Pre-treatment GlycA measurement provides no additional predictive utility beyond routine clinical measures in patients with rheumatoid arthritis.

作者信息

Ling Stephanie F, Yap Chuan Fu, Nair Nisha, Verstappen Suzanne M M, Morgan Ann W, Isaacs John D, Wilson Anthony G, Hyrich Kimme L, Barton Anne, Plant Darren

机构信息

Centre for Genetics and Genomics Versus Arthritis, Centre for Musculoskeletal Research, The University of Manchester, Manchester, UK.

NIHR Manchester Biomedical Research Centre, Manchester University NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK.

出版信息

Rheumatology (Oxford). 2025 Jul 1;64(7):4417-4419. doi: 10.1093/rheumatology/keaf235.

DOI:10.1093/rheumatology/keaf235
PMID:40358550
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12212900/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c005/12212900/b4c969eb34ff/keaf235f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c005/12212900/b4c969eb34ff/keaf235f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c005/12212900/b4c969eb34ff/keaf235f1.jpg

相似文献

1
Pre-treatment GlycA measurement provides no additional predictive utility beyond routine clinical measures in patients with rheumatoid arthritis.在类风湿性关节炎患者中，治疗前糖基化终末产物（GlycA）测量在常规临床指标之外并无额外的预测作用。
Rheumatology (Oxford). 2025 Jul 1;64(7):4417-4419. doi: 10.1093/rheumatology/keaf235.
2
Exercise for rheumatoid arthritis of the hand.手部类风湿性关节炎的运动疗法
Cochrane Database Syst Rev. 2018 Jul 31;7(7):CD003832. doi: 10.1002/14651858.CD003832.pub3.
3
Celecoxib for rheumatoid arthritis.塞来昔布用于类风湿性关节炎。
Cochrane Database Syst Rev. 2017 Jun 9;6(6):CD012095. doi: 10.1002/14651858.CD012095.pub2.
4
Combination therapy for pain management in inflammatory arthritis (rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, other spondyloarthritis).炎症性关节炎（类风湿性关节炎、强直性脊柱炎、银屑病关节炎、其他脊柱关节炎）疼痛管理的联合治疗
Cochrane Database Syst Rev. 2011 Oct 5(10):CD008886. doi: 10.1002/14651858.CD008886.pub2.
5
Safety of non-steroidal anti-inflammatory drugs, including aspirin and paracetamol (acetaminophen) in people receiving methotrexate for inflammatory arthritis (rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, other spondyloarthritis).非甾体抗炎药（包括阿司匹林和对乙酰氨基酚）在接受甲氨蝶呤治疗炎性关节炎（类风湿关节炎、强直性脊柱炎、银屑病关节炎、其他脊柱关节炎）患者中的安全性。
Cochrane Database Syst Rev. 2011 Nov 9(11):CD008872. doi: 10.1002/14651858.CD008872.pub2.
6
Nursing sensitive outcomes in patients with rheumatoid arthritis: A systematic literature review.类风湿关节炎患者的护理敏感结局：系统文献回顾。
Int J Nurs Stud. 2018 Jan;77:115-129. doi: 10.1016/j.ijnurstu.2017.09.005. Epub 2017 Sep 12.
7
What is the added value of ultrasound joint examination for monitoring synovitis in rheumatoid arthritis and can it be used to guide treatment decisions? A systematic review and cost-effectiveness analysis.超声关节检查在监测类风湿关节炎滑膜炎方面的附加值是什么，它能否用于指导治疗决策？系统评价和成本效益分析。
Health Technol Assess. 2018 Apr;22(20):1-258. doi: 10.3310/hta22200.
8
Utility of a novel inflammatory marker, GlycA, for assessment of rheumatoid arthritis disease activity and coronary atherosclerosis.新型炎症标志物GlycA在评估类风湿性关节炎疾病活动度和冠状动脉粥样硬化中的应用
Arthritis Res Ther. 2015 May 9;17(1):117. doi: 10.1186/s13075-015-0646-x.
9
Patient-Reported Outcome Measures After Direct Anterior Total Hip Arthroplasty Are Comparable Between Patients With Rheumatoid Arthritis and Osteoarthritis: A Propensity-Matched Analysis.类风湿关节炎和骨关节炎患者直接前路全髋关节置换术后的患者报告结局指标比较：一项倾向匹配分析
J Am Acad Orthop Surg. 2025 Jun 15;33(12):637-643. doi: 10.5435/JAAOS-D-24-00656. Epub 2024 Oct 1.
10
Biologics or tofacitinib for people with rheumatoid arthritis unsuccessfully treated with biologics: a systematic review and network meta-analysis.生物制剂或托法替布用于生物制剂治疗类风湿关节炎失败的患者：一项系统评价和网状Meta分析
Cochrane Database Syst Rev. 2017 Mar 10;3(3):CD012591. doi: 10.1002/14651858.CD012591.

本文引用的文献

1
GlycA Levels during the Earliest Stages of Rheumatoid Arthritis: Potential Use as a Biomarker of Subclinical Cardiovascular Disease.类风湿关节炎早期阶段的糖化白蛋白水平：作为亚临床心血管疾病生物标志物的潜在用途。
J Clin Med. 2020 Aug 1;9(8):2472. doi: 10.3390/jcm9082472.
2
Prediction of primary non-response to methotrexate therapy using demographic, clinical and psychosocial variables: results from the UK Rheumatoid Arthritis Medication Study (RAMS).利用人口统计学、临床和心理社会变量预测甲氨蝶呤治疗的原发性无反应：来自英国类风湿关节炎药物研究（RAMS）的结果。
Arthritis Res Ther. 2018 Jul 13;20(1):147. doi: 10.1186/s13075-018-1645-5.
3
A novel inflammatory biomarker, GlycA, associates with disease activity in rheumatoid arthritis and cardio-metabolic risk in BMI-matched controls.
一种新型炎症生物标志物GlycA与类风湿关节炎的疾病活动以及体重指数匹配的对照人群的心血管代谢风险相关。
Arthritis Res Ther. 2016 Apr 12;18:86. doi: 10.1186/s13075-016-0982-5.
4
GlycA: A Composite Nuclear Magnetic Resonance Biomarker of Systemic Inflammation.糖氨聚糖：一种全身性炎症的综合核磁共振生物标志物。
Clin Chem. 2015 May;61(5):714-23. doi: 10.1373/clinchem.2014.232918. Epub 2015 Mar 16.
5
MissForest--non-parametric missing value imputation for mixed-type data.MissForest--用于混合类型数据的非参数缺失值插补。
Bioinformatics. 2012 Jan 1;28(1):112-8. doi: 10.1093/bioinformatics/btr597. Epub 2011 Oct 28.
6
Association of rheumatoid factor and anti-cyclic citrullinated peptide positivity, but not carriage of shared epitope or PTPN22 susceptibility variants, with anti-tumour necrosis factor response in rheumatoid arthritis.类风湿关节炎中类风湿因子和抗环瓜氨酸肽阳性与抗肿瘤坏死因子反应相关，但共同表位或PTPN22易感变异的携带情况与之无关。
Ann Rheum Dis. 2009 Jan;68(1):69-74. doi: 10.1136/ard.2007.084715. Epub 2008 Mar 28.